SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-17-001459
Filing Date
2017-03-10
Accepted
2017-03-10 08:12:30
Documents
88
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2231221z10-k.htm 10-K 1512549
2 EX-21.1 a2231221zex-21_1.htm EX-21.1 4553
3 EX-23.1 a2231221zex-23_1.htm EX-23.1 2629
4 EX-31.1 a2231221zex-31_1.htm EX-31.1 7520
5 EX-31.2 a2231221zex-31_2.htm EX-31.2 7595
6 EX-32.1 a2231221zex-32_1.htm EX-32.1 5814
13 G374364.JPG g374364.jpg GRAPHIC 60050
14 G549798.JPG g549798.jpg GRAPHIC 89900
15 G980029.JPG g980029.jpg GRAPHIC 66073
16 G431724.JPG g431724.jpg GRAPHIC 45365
  Complete submission text file 0001047469-17-001459.txt   8544696

Data Files

Seq Description Document Type Size
7 EX-101.INS crvs-20161231.xml EX-101.INS 2159378
8 EX-101.SCH crvs-20161231.xsd EX-101.SCH 57170
9 EX-101.CAL crvs-20161231_cal.xml EX-101.CAL 63069
10 EX-101.DEF crvs-20161231_def.xml EX-101.DEF 178684
11 EX-101.LAB crvs-20161231_lab.xml EX-101.LAB 535612
12 EX-101.PRE crvs-20161231_pre.xml EX-101.PRE 392491
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37719 | Film No.: 17680248
SIC: 2834 Pharmaceutical Preparations